Transforming Cancer Care with AI Precision Medicine
Ataraxis AI is an AI precision medicine company building foundation models for oncology that empower physicians to personalize cancer treatment. Their flagship product, Ataraxis Breast, is the first clinically available AI-native breast cancer platform that analyzes multi-modal patient data to predict outcomes and guide treatment selection, reducing unnecessary chemotherapy.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create a free account to see which investors have funded this company.
Create Free Account